Cefuroxime and Hepatic function abnormal - a phase IV clinical study of FDA data

Summary:

Hepatic function abnormal is reported as a side effect among people who take Cefuroxime (cefuroxime sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Famotidine, and have High blood pressure.

The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Cefuroxime. It is created by eHealthMe based on reports of 12,808 people who have side effects when taking Cefuroxime from the FDA, and is updated regularly.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,437 drugs and 2,021 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.

On Aug, 11, 2026

12,808 people reported to have side effects when taking Cefuroxime.
Among them, 49 people (0.38%) have Hepatic function abnormal.

Could Cefuroxime cause Hepatic function abnormal?

Among these 49 people:

How long have people been on Cefuroxime when they have Hepatic function abnormal? *

What is the gender of people who have Hepatic function abnormal when taking Cefuroxime? *

female: 31.91 %
male: 68.09 %

What is the age of people who have Hepatic function abnormal when taking Cefuroxime? *

What are other drugs people take besides Cefuroxime? *

What are other side effects people have besides Hepatic function abnormal? *

Fever: 8 people, 16.33%
Alanine Aminotransferase Increased: 7 people, 14.29%
Hypotension (abnormally low blood pressure): 6 people, 12.24%
Rashes (redness): 6 people, 12.24%
Anaemia (lack of blood): 5 people, 10.20%
Dizziness: 5 people, 10.20%
Bradycardia (abnormally slow heart action): 5 people, 10.20%
Aspartate Aminotransferase Increased: 5 people, 10.20%
Itching: 5 people, 10.20%
Acute Kidney Failure: 5 people, 10.20%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 10.20%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 8.16%
Infection: 3 people, 6.12%
Dacryostenosis Acquired (obstruction of the nasolacrimal duct-acquired): 3 people, 6.12%
Pterygium (benign growth of the conjunctiva): 3 people, 6.12%
Prostate Cancer: 3 people, 6.12%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 6.12%
Depression: 3 people, 6.12%
Hypoglycemia (low blood sugar): 2 people, 4.08%
Urination - Painful: 2 people, 4.08%

* Approximation only. Some reports may have incomplete information.

Do you take Cefuroxime and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefuroxime:

Cefuroxime (12,999 reports)

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic function abnormal:

Hepatic function abnormal (1,437 drugs)

Browse all the conditions that are associated with Hepatic function abnormal:

Hepatic function abnormal (2,021 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime sodium (the active ingredients of Cefuroxime) and Cefuroxime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.